Indication*

Duodenal ulcer, Gastric ulcer, Nonsteroidal Anti-Inflammatory Drug (NSAID) associated gastric and duodenal ulcers or erosions Helicobacter pylori eradication in peptic ulcer disease. Reflux oesophangitis. Symptomatic gastro-oesophageal reflux disease. Treatment of erosive reflux oesophangitis, Long-term maintenance therapy to prevent reflux oesophagitis, Acid-related dyspepsia, Zollinger-Ellison syndrome, Refractory peptic ulcer, Prophylaxis of acid aspiration.

Directions for Use*

Doudenal ulcer_ Usually 20 mg once daily for 2 weeks; if not fully healed, treatment may be extended for a further 2 weeks. In refractory case, 40 mg once daily for 4 weeks. Gastric ulcer and relux oesophagitis_ 20 mg once daily for 4 weeks; if not fully healed, treatment may be extended for further 4 weeks. In refractory cases, 40 mg once daily for 8 weeks. Prevention of relapses in patients with severe reflux oesophagitis- 20 mg once daily. In case of recurrence, the dose can be increased to 40 mg once daily. Helicobacter pylori-associated peptic ulcer disease-40-80 mg with amoxicillin. 1.5 to 3g daily in divided doses for 2 weeks or 40 mg daily with clarithromycin 500 mg thrice daily for 2 weeks. Zollinger-Ellison Syndrome- 60 mg once daily adjusted to response. Usual maintenance -20 to 120mg daily. Doses over 80mg daily, can be given in two divided doses. Prophylaxis of acid aspiration-Omeprazole 40mg in the evening before surgery and 40mg 2-6 hours before surgery.

Administration*

*written indications, directions, and administration are updated as of January 28, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.

Share

Share

Link

Close share Copy link

View full details